Matthew McCormick
Papers
1
Total Citations
16
H-Index
1
About
Dr. Matthew McCormick is a pioneering biomedical engineer whose research bridges the gap between clinical ultrasound technologies and preclinical drug development. His primary focus lies in developing advanced shear wave elastography (SWE) systems—ultrasound-based stiffness quantification tools—for noninvasive assessment of liver disease. His landmark 2022 study, "Development of a Robotic Shear Wave Elastography System for Noninvasive Staging of Liver Disease in Murine Models" (16 citations), represents a transformative contribution to the field. By adapting clinically proven SWE technology for use in small animal models, Dr. McCormick has created a powerful platform that enables researchers and pharmaceutical developers to track liver fibrosis progression in real time without sacrificing animals. This innovation addresses a critical bottleneck in preclinical research, where traditional histology requires terminal procedures. His work has been recognized for its potential to accelerate drug screening for nonalcoholic steatohepatitis and other chronic liver conditions. Dr. McCormick’s robotic system achieves unprecedented precision and reproducibility, making him a leading voice in translational ultrasound imaging and a key figure in advancing noninvasive biomarkers for liver disease.
Research Focus
Key Achievements
Top Papers
- 1